Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Meihua Pharmaceutical Co., Ltd. is a China-based pharmaceutical company and a key subsidiary of Tianjin Lisheng Pharmaceutical Co., Ltd. The company focuses on the production and distribution of chemical drug preparations, including tablets, capsules, and granules, as well as active pharmaceutical ingredients (APIs). Its therapeutic focus primarily covers cardiovascular health, anti-infectives, and digestive system treatments. Operating out of Tianjin, the company maintains high-standard manufacturing facilities that adhere to national GMP requirements, supporting the broader portfolio of its parent organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Meihua Pharmaceutical.